Mark Hodson is a seasoned sales professional with extensive experience in the biotechnology and pharmaceutical sectors, currently serving as Head of Sales for Revvity's Pre-Clinical Services since May 2023. Prior roles include Head of Strategic Accounts at Horizon Discovery, where collaboration with global pharmaceutical companies focused on gene modulation and mechanism of action studies. Mark's expertise encompasses functional genomic screens, cell line engineering, and diagnostic reference material production. Previous positions held include Gene Modulation and Oligo Production Specialist and Oligonucleotide Production Specialist at GE Healthcare, and Molecular Biology Sales Specialist at Thermo Fisher Scientific. Mark holds a Ph.D. in Molecular Biology and RNA Biochemistry and a Bachelor's degree in Biochemistry, both from the University of Leicester.
This person is not in any teams
This person is not in any offices